Pfizer, a major American pharmaceutical company, and Biontech, a German company, have confirmed the safety and efficacy of a new coronavirus vaccine in clinical trials in children aged 12 to 15 years who are not currently eligible for vaccination. Announced.
The vaccine developed by Pfizer and others is currently targeted at people aged 16 and over, but the two companies have conducted clinical trials on 2,260 people aged 12 to 15 in the United States to see if the vaccine is safe and effective for children. The results were announced on March 31st.
According to the report,
18 people were confirmed to have symptoms of coronavirus infection in the group of 1129 people who received a placebo called "placebo", while
the group of 1131 people who were vaccinated had symptoms. It means that there were no people.
Side reactions were also generally consistent with those seen in another clinical trial involving 16 to 25 years of age.
Regarding the inoculation of the new coronavirus vaccine to children,
▽ Pfizer has already started clinical trials for
children
aged 6 months to 11 years, and
▽ American pharmaceutical company Modelna is also 6 months to under 18 years old. the clinical trial was to subject,
also,
▽ Oxford has developed a British pharmaceutical giant AstraZeneca and vaccine University also conducted clinical trials in 17 years from 6 years old.
Pfizer and Biontech will submit this data to the FDA = US Food and Drug Administration and EMA = European Medicines Agency to apply for an emergency use authorization.